Decreased plasma endothelin-1 levels in asymptomatic type I diabetic patients with regional cerebral hypoperfusion assessed by SPECT

Journal of Diabetes and its Complications

Volumn 13, Issue 5-6, 1999, Pages 325-331

  Vázquez, Luis A ^a   Amado, José A ^a   García Unzueta, María T ^a   Quirce, Remedios ^a   Jiménez Bonilla, Julio F ^a   Pazos, Fernando ^a   Pesquera, Carlos ^a   Carril, José M ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; HEMOGLOBIN A1C; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M;

ADULT; ARTICLE; BODY MASS; BRAIN BLOOD FLOW; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; HUMAN; HUMAN EXPERIMENT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; BRAIN; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; CHOLESTEROL; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; ENDOTHELIN-1; FEMALE; HUMANS; MALE; REFERENCE VALUES; REGIONAL BLOOD FLOW; REGRESSION ANALYSIS; SMOKING; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0342424707     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(99)00064-1     Document Type: Article

References (30)

1. Bell D.S.H. Stroke in the diabetic patient. Diabetes Care. 17:1994;213-219.
2. Chukwuma C., Tuomilehto J. Diabetes and the risk of stroke. J Diabet Complications. 7:1993;250-262.
3. Stegmayr B., Asplund K. Diabetes as a risk factor for stroke. A population perspective. Diabetologia. 38:1995;1061-1068.
4. Jiménez-Bonilla J.F., Carril J.M., Quirce R., Gómez-Barquín R., Amado J.A., Gutiérrez-Mendiguchía C. Assessment of cerebral blood flow in diabetic patients with no clinical history of neurological disease. Nucl Med Commun. 17:1996;790-794.
5. Keymulen B., Jacobs A., De Metz K., De Sadeleer C., Bossuyt A., Somers G. Regional cerebral hypoperfusion in long-term type 1 (insulin-dependent) diabetic patients. relation to hypoglycemic events Nucl Med Commun. 16:1995;10-16.
6. 123-p-iodoamphetamine with single-photon emission computed tomography. J Diabet Complications. 4:1990;170-174.
7. 123 -IMP with SPECT Nucl Med Commun. 15:1994;455-460.
8. 99mTc-HMPAO SPET in type I diabetic patients with no clinical history of cerebrovascular disease. Eur J Nucl Med. 24:1997;1507-1513.
9. Keymulen B., de Metz K., Cluydts R., Bossuyt A., Somers G. Technetium-99m hexamethylpropylene amine oxime single-photon emission tomography of regional cerebral blood flow in insulin-dependent diabetes. Eur J Nucl Med. 23:1996;163-168.
10. Levin E.R. Endothelins. N Engl J Med. 333:1995;356-363.
11. Haynes W.G., Webb D.J. Endothelin. a long-acting local constrictor hormone Br J Hosp Med. 47:1992;340-349.
12. Ziv I., Fleminger G., Djaldetti R., Achiron A., Melamed E., Sokolovsky M. Increased plasma endothelin-1 in acute ischemic stroke. Stroke. 23:1992;1014-1016.
13. Estrada V., Téllez M.J., Moya J., Fernández-Durango R., Egido J., Fernández-Cruz A.F. High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke. Am J Hypertens. 7:1994;1085-1089.
14. Haak T., Jungmann E., Felber A., Hillmann U., Usadel K.H. Increased plasma levels of endothelin in diabetic patients with hypertension. Am J Hypertens. 5:1992;161-166.
15. Collier A., Leach J.P., McLellan A., Jardine A., Morton J.J., Small M. Plasma endothelinlike immunoreactivity levels in IDDM patients with microalbuminuria. Diabetes Care. 15:1992;1038-1040.
16. Takahashi K., Ghatei M.A., Lam H.-C., O'Halloran D.J., Bloom S.R. Elevated plasma endothelin in patients with diabetes mellitus. Diabetologia. 33:1990;306-310.
17. Kirilov G., Dakovska L., Borisova A.M., Krivoshiev S., Nentchev N. Increased plasma endothelin levels in patients with insulin-dependent diabetes mellitus and end stage vascular complications. Horm Metab Res. 26:1994;119-120.
18. Holman B.L., Devous M.D., Functional brain S.P.E.C.T. The emergence of a powerful clinical method. J Nucl Med. 33:1992;1888-1904.
19. Mohr J.P. Lacunes. Barnett H.J.M., Stein B.M., Mohr J.P., Yatsu F.M. Stroke Pathophysiology, Diagnosis and Management. Vol. 2. 1986;475-496 Churchill Livingstone, New York.
20. Dandona P., James I.M., Newbury P.A., Woollard M.L., Beckett A.G. Cerebral blood flow in diabetes mellitus. Evidence of abnormal cerebrovascular reactivity Br Med J. 2:1978;325-326.
21. Griffith D.N.W., Saimbi S., Lewis C., Tolfree S., Betteridge D.J. Abnormal cerebrovascular carbon dioxide reactivity in people with diabetes. Diabetic Med. 4:1987;217-220.
22. Tsunoda K., Abe K., Sato T., Yokosawa S., Yoshinaga K. Decreased conversion of big endothelin-1 in patients with diabetes mellitus. Clin Exp Pharmacol Physiol. 18:1991;731-732.
23. Pieper G.M. Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus. Importance of disease duration Diabetologia. 42:1999;204-213.
24. Lerman A., Edwards B.S., Hallett J.W., Heublein D.M., Sandberg S.M., Burnett J.C. Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 325:1991;997-1001.
25. Polderman K.H., Stehouwer C.D., van Kamp G.J., Dekker G.A., Verheugt F.W., Gooren L.J. Influence of sex hormones on plasma endothelin levels. Ann Intern Med. 118:1993;429-432.
26. Momose N., Fukuo K., Morimoto S., Ogihara T. Captopril inhibits endothelin-1 secretion from endothelial cells through bradykinin. Hypertension. 21:1993;921-924.
27. Desideri G., Ferri C., Bellini C., de Mattia G., Santucci A. Effects of ACE inhibition on spontaneous and insulin-stimulated endothelin-1 secretion. in vitro and in vivo studies Diabetes. 46:1997;81-86.
28. Ferri C., Laurenti O., Bellini C., Faldetta M.R., Properzi G., Santucci A., De Mattia G. Circulating endothelin-1 levels in lean non-insulin-dependent diabetic patients. Influence of ACE inhibition. Am J Hypertens. 8:1995;40-47.
29. Cacoub P., Koskas F., Timsit S., Maistre G., Gatel A., Piette J.C., Godeau P., Carayon A., Kieffer E. Decrease in internal jugular endothelin levels after carotid cross-clamping during human carotid revascularization procedures. Ann Vasc Surg. 10:1996;239-243.
30. Kawamura T., Umemura T., Kanai A., Uno T., Matsumae H., Sano T., Sakamoto N., Sakakibara T., Nakamura J., Hotta N. The incidence and characteristics of silent cerebral infarction in elderly diabetic patients. association with serum-soluble adhesion molecules Diabetologia. 41:1998;911-917.